ARTICLE | Financial News
Avrobio proposes $86.3M NASDAQ IPO
June 1, 2018 7:14 PM UTC
Avrobio Inc. (Cambridge, Mass.) proposed on May 25 to raise $86.3 million in an IPO underwritten by Morgan Stanley, Cowen, Wells Fargo and Wedbush PacGrow.
In February, the cell therapy company raised $60 million in a series B round led by Cormorant Asset Management and Surveyor Capital (see BioCentury, Feb. 2)...
BCIQ Company Profiles